During the past decade, Sanatorio de la Mujer conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanatorio de la Mujer" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "CanariaBio Inc." with 1 trials sponsored, "Geron Corporation" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanatorio de la Mujer" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Genmab" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Latin American Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sanatorio de la Mujer" are "Cardiovascular Disease" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Cervical Cancer" (1 trials) and "Fallopian Tube Adenocarcinoma" (1 trials). Many other conditions were trialed in "Sanatorio de la Mujer" in a lesser frequency.

Most popular intervention types in "Sanatorio de la Mujer" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Atezolizumab" (3 trials), "Best Available Therapy (BAT)" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Ado-trastuzumab emtamsine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sanatorio de la Mujer" are 8 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sanatorio de la Mujer". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sanatorio de la Mujer, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sanatorio de la Mujer, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".